BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 1701794)

  • 1. Cellular and metabolic requirements for induction of macrophage procoagulant activity by murine hepatitis virus strain 3 in vitro.
    Chung S; Sinclair S; Leibowitz J; Skamene E; Fung LS; Levy G
    J Immunol; 1991 Jan; 146(1):271-8. PubMed ID: 1701794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistance of naive mice to murine hepatitis virus strain 3 requires development of a Th1, but not a Th2, response, whereas pre-existing antibody partially protects against primary infection.
    Pope M; Chung SW; Mosmann T; Leibowitz JL; Gorczynski RM; Levy GA
    J Immunol; 1996 May; 156(9):3342-9. PubMed ID: 8617959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Susceptibility/resistance to mouse hepatitis virus strain 3 and macrophage procoagulant activity are genetically linked and controlled by two non-H-2-linked genes.
    Dindzans VJ; Skamene E; Levy GA
    J Immunol; 1986 Oct; 137(7):2355-60. PubMed ID: 3020124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Th1 cell line (3E9.1) from resistant A/J mice inhibits induction of macrophage procoagulant activity in vitro and protects against MHV-3 mortality in vivo.
    Chung S; Gorczynski R; Cruz B; Fingerote R; Skamene E; Perlman S; Leibowitz J; Fung L; Flowers M; Levy G
    Immunology; 1994 Nov; 83(3):353-61. PubMed ID: 7835959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The immune response to mouse hepatitis virus: expression of monocyte procoagulant activity and plasminogen activator during infection in vivo.
    Dindzans VJ; MacPhee PJ; Fung LS; Leibowitz JL; Levy GA
    J Immunol; 1985 Dec; 135(6):4189-97. PubMed ID: 2999239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of resistance to murine hepatitis virus strain 3 infection after treatment with corticosteroids is associated with induction of macrophage procoagulant activity.
    Fingerote RJ; Abecassis M; Phillips MJ; Rao YS; Cole EH; Leibowitz J; Levy GA
    J Virol; 1996 Jul; 70(7):4275-82. PubMed ID: 8676449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibody analysis of a unique macrophage procoagulant activity induced by murine hepatitis virus strain 3 infection.
    Fung LS; Neil G; Leibowitz J; Cole EH; Chung S; Crow A; Levy GA
    J Biol Chem; 1991 Jan; 266(3):1789-95. PubMed ID: 1846363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 16, 16 Dimethyl prostaglandin E2 prevents the development of fulminant hepatitis and blocks the induction of monocyte/macrophage procoagulant activity after murine hepatitis virus strain 3 infection.
    Abecassis M; Falk JA; Makowka L; Dindzans VJ; Falk RE; Levy GA
    J Clin Invest; 1987 Sep; 80(3):881-9. PubMed ID: 3624490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of accessory cell function during acute infection of BALB/cByJ mice with mouse hepatitis virus (MHV), strain JHM.
    de Souza MS; Smith AL
    Lab Anim Sci; 1991 Apr; 41(2):112-8. PubMed ID: 1658437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 2',5'-oligoadenylate analogue inhibits murine hepatitis virus strain 3 (MHV-3) replication in vitro but does not reduce MHV-3-related mortality or induction of procoagulant activity in susceptible mice.
    Fingerote RJ; Cruz BM; Gorczynski RM; Fung LS; Hubbell HR; Suhadolnik RJ; Levy GA
    J Gen Virol; 1995 Feb; 76 ( Pt 2)():373-80. PubMed ID: 7844557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural cytotoxicity against mouse hepatitis virus-infected target cells. I. Correlation of cytotoxicity with virus binding to leukocytes.
    Holmes KV; Welsh RM; Haspel MV
    J Immunol; 1986 Feb; 136(4):1446-53. PubMed ID: 3003198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of monocyte procoagulant activity by murine hepatitis virus type 3 parallels disease susceptibility in mice.
    Levy GA; Leibowitz JL; Edgington TS
    J Exp Med; 1981 Oct; 154(4):1150-63. PubMed ID: 6270227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ribavirin inhibits viral-induced macrophage production of TNF, IL-1, the procoagulant fgl2 prothrombinase and preserves Th1 cytokine production but inhibits Th2 cytokine response.
    Ning Q; Brown D; Parodo J; Cattral M; Gorczynski R; Cole E; Fung L; Ding JW; Liu MF; Rotstein O; Phillips MJ; Levy G
    J Immunol; 1998 Apr; 160(7):3487-93. PubMed ID: 9531310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of monocyte-macrophage procoagulant activity by transformed cell lines.
    Rambaldi A; Alessio G; Casali B; Passerini CG; Donati MB; Mantovani A; Semeraro N
    J Immunol; 1986 May; 136(10):3848-55. PubMed ID: 3701063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Host genetic control of mouse hepatitis virus type-4 (JHM strain) replication. II. The gene locus for susceptibility is linked to the Svp-2 locus on mouse chromosome 7.
    Knobler RL; Taylor BA; Wooddell MK; Beamer WG; Oldstone MB
    Exp Clin Immunogenet; 1984; 1(4):217-22. PubMed ID: 6101098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An innate host response to the neoplastic cell: syngeneic rat tumor cells can elicit a rapid de novo lymphoid procoagulant response.
    Lando PA; Edgington TS
    J Immunol; 1985 Nov; 135(5):3587-95. PubMed ID: 4045197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of alterations in early signal transduction events on the induction of procoagulant activity by murine hepatitis virus strain 3 in vitro.
    Chung SW; Rotstein OD; Downey GP; Levy GA
    J Gen Virol; 1995 May; 76 ( Pt 5)():1181-7. PubMed ID: 7730802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-virulent mouse hepatitis viruses exhibiting various tropisms in macrophages, T and B cell subpopulations, and thymic stromal cells.
    Lamontagne L; Jolicoeur P
    Lab Anim Sci; 1994 Feb; 44(1):17-24. PubMed ID: 8007655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antiprothrombinase (3D4.3) prevents mortality from murine hepatitis virus (MHV-3) infection.
    Li C; Fung LS; Chung S; Crow A; Myers-Mason N; Phillips MJ; Leibowitz JL; Cole E; Ottaway CA; Levy G
    J Exp Med; 1992 Sep; 176(3):689-97. PubMed ID: 1324969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T lymphocyte-dependent difference in susceptibility between DDD and C3H mice to mouse hepatitis virus, MHV-3.
    Yamada A; Taguchi F; Fujiwara K
    Jpn J Exp Med; 1979 Dec; 49(6):413-21. PubMed ID: 232196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.